Key Insights

Highlights

Success Rate

56% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 90/100

Termination Rate

33.3%

4 terminated out of 12 trials

Success Rate

55.6%

-31.0% vs benchmark

Late-Stage Pipeline

25%

3 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

56% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (6)
Early P 1 (1)
P 3 (3)

Trial Status

Completed5
Terminated4
Unknown2
Recruiting1

Trial Success Rate

55.6%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT01563796Terminated

Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer

NCT05439902Not ApplicableRecruiting

Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women

NCT03537534Phase 3TerminatedPrimary

Intraurethral Lidocaine After Endourology Procedures

NCT04228692Not ApplicableCompleted

Percutaneous Posterior Tibial Nerve Stimulation in Post-operative Voiding Dysfunction After Deep Endometriosis Surgery

NCT05152199Not ApplicableTerminatedPrimary

Pain Outcomes During Rigid Cystoscopy in Females With and Without Cystoscopic Sheath Obturator

NCT03474887Completed

Digital Online Consultations - Effects on Antibiotic Prescribing and Health Care Utilization in Primary Care

NCT05156502Not ApplicableUnknown

To Assess Signs and Symptoms in Women Affected by GSM After One Cycle of Pixel CO2-Alma Fractionated Laser

NCT01657448Phase 3CompletedPrimary

Efficacy Study of Methenamine + Methylthioninium Chloride vs Phenazopyridine for the Symptomatic Control of Dysuria

NCT03210038Not ApplicableCompleted

Cystoscopy in Females: Is There a Difference Between Rigid and Flex Cystoscopy, and Does it Require Local Anasthesia?

NCT03185169Early Phase 1Terminated

GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors

NCT02554201Not ApplicableCompleted

Efficacy of Electrical Pudendal Nerve Stimulation for Neurogenic Lower Urinary Tract Dysfunction

NCT00969254Phase 3UnknownPrimary

Study to Assess the Efficacy and Safety of "Pílulas de Lussen®" Compared to the Pyridium® in the Symptomatic Control of Dysuria

Showing all 12 trials

Research Network

Activity Timeline